Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07317297 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 16, 2026 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2, 2026 to Jan 10, 2026
    • Site details revised
    v3
  2. Primary endpoints revised (2)
    • Interventions: control (Other), eswt (Other) to Extracorporeal Shockwave Therapy (Other), control (Other)
    • Eligibility criteria shortened, about 1 word
    • Study description shortened, about 1 word
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.
Trial Details
NCT Number NCT07317297
Lead Sponsor Uskudar University
Conditions
(from sponsor)		 Peyronie Disease
Related terms Penile Induration
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov